PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Pharvaris N.V.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026
$29.77+2.03 (+7.32%)
Close on Oct 19, 2026
Ownership
Who owns Pharvaris's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 71 sales
Net sold $33.02M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| General Atlantic Cooperatief U.A. | 5,359,727 | 7.60% | 13G (passive) amendment | Jun 30, 2026 |
| FMR LLC | 5,192,984 | 9.99% | 13G (passive) amendment | Feb 9, 2024 |
| Corey Goodman | 4,382,504 | 8.40% | 13D (active) amendment | Jan 24, 2024 |
| Foresite Capital Management IV, LLC (“FCM IV”) | 4,038,842 | 7.80% | 13G (passive) amendment | Dec 31, 2023 |
| Shabet Rose Sharon | 3,653,310 | 5.60% | 13G (passive) amendment | Mar 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Berndt Modig | Chief Executive Officer, Director | 778,334 | 1.19% | Sep 21, 2026 |
| Peng Lu | President | 110,261 | 0.17% | Sep 24, 2026 |
| David W. Nassif | CFO / CLO | 114,300 | 0.18% | Sep 23, 2026 |
| Anne Lesage | Chief Early Development | 130,419 | 0.20% | Sep 21, 2026 |
| Stefan Andreas Abele | Chief Technical Ops Officer | 40,468 | 0.06% | Sep 17, 2026 |
| Wim Souverijns | Chief Commercial Officer | 39,021 | 0.06% | Sep 16, 2026 |
| Anna Nijdam | Principal Accounting Officer | 46,275 | 0.07% | Jun 8, 2026 |
| Annick Deschoolmeester | Chief Human Resources Officer | 92,553 | 0.14% | Mar 18, 2026 |
| Viviane Monges | Director | 17,469 | 0.03% | Sep 25, 2026 |
| Johannes Gerardus Christiaan Petrus Schikan | Director | 115,167 | 0.18% | Sep 24, 2026 |
| Robert Glassman | Director | 10,500 | 0.02% | Sep 21, 2026 |
| Elisabeth Bjork | Director | 15,167 | 0.02% | Sep 21, 2026 |
| David P. Meeker | Director | 65,167 | 0.10% | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Viviane Monges Director | Sep 23, 2026 | Option exercise | +11,969 | $8.05 | $96.35K | 17,469 |
| Viviane Monges Director | Sep 23, 2026 | Sale | −11,969 | $33.05 | $395.58K | 5,500 |
| Peng Lu President | Sep 22, 2026 | Option exercise | +45,308 | $2.59 | $117.35K | 110,261 |
| Johannes Gerardus Christiaan Petrus Schikan Director | Sep 22, 2026 | Sale | −800 | $36.19 | $28.95K | 115,167 |
| Johannes Gerardus Christiaan Petrus Schikan Director | Sep 22, 2026 | Option exercise | +800 | $20.00 | $16.00K | 115,967 |
| David W. Nassif CFO / CLO | Sep 21, 2026 | Sale | −6,000 | $36.47 | $218.82K | 114,300 |
| David W. Nassif CFO / CLO | Sep 21, 2026 | Gift | −500 | – | – | 113,800 |
| Anne Lesage Chief Early Development | Sep 17, 2026 | Sale | −20,000 | $38.27 | $765.40K | 73,969 |
| Robert Glassman Director | Sep 17, 2026 | Sale(10b5-1 plan) | −14,493 | $38.56 | $558.85K | 10,500 |
| Robert Glassman Director | Sep 17, 2026 | Option exercise | +14,493 | $18.14 | $262.90K | 24,993 |
| Peng Lu President | Sep 17, 2026 | Sale | −100,000 | $35.00 | $3.50M | 64,953 |
| Peng Lu President | Sep 17, 2026 | Option exercise | +100,000 | $2.59 | $259.00K | 164,953 |
| Johannes Gerardus Christiaan Petrus Schikan Director | Sep 17, 2026 | Sale | −200,000 | $35.00 | $7.00M | 115,167 |
| Elisabeth Bjork Director | Sep 17, 2026 | Sale | −52,500 | $37.89 | $1.99M | 15,167 |
| Elisabeth Bjork Director | Sep 17, 2026 | Option exercise | +17,500 | $18.14 | $317.45K | 67,667 |
| Elisabeth Bjork Director | Sep 17, 2026 | Option exercise | +35,000 | $14.39 | $503.65K | 50,167 |
| Berndt Modig Chief Executive Officer, Director | Sep 17, 2026 | Option exercise | −300,000 | $35.00 | $10.50M | 650,000 |
| Robert Glassman Director | Sep 15, 2026 | Sale(10b5-1 plan) | −8,667 | $38.27 | $331.69K | 10,500 |
| Robert Glassman Director | Sep 15, 2026 | Option exercise | +8,667 | $22.31 | $193.36K | 19,167 |
| Stefan Andreas Abele Chief Technical Ops Officer | Sep 15, 2026 | Sale | −45,000 | $38.14 | $1.72M | 40,468 |
| Stefan Andreas Abele Chief Technical Ops Officer | Sep 15, 2026 | Option exercise | +45,000 | $16.40 | $738.00K | 85,468 |
| Stefan Andreas Abele Chief Technical Ops Officer | Sep 15, 2026 | Sale | −1,400 | $39.24 | $54.94K | 39,068 |
| Wim Souverijns Chief Commercial Officer | Sep 15, 2026 | Sale(10b5-1 plan) | −6,090 | $38.99 | $237.45K | 39,021 |
| Wim Souverijns Chief Commercial Officer | Sep 14, 2026 | Option exercise | +20,000 | $17.43 | $348.60K | 65,111 |
| Wim Souverijns Chief Commercial Officer | Sep 14, 2026 | Sale(10b5-1 plan) | −20,000 | $39.31 | $786.20K | 45,111 |
| Berndt Modig Chief Executive Officer, Director | Sep 14, 2026 | Sale(10b5-1 plan) | −2,291 | $39.40 | $90.27K | 128,334 |
| Peng Lu President | Sep 14, 2026 | Tax withholding | −117 | $38.02 | $4.45K | 64,953 |
| Peng Lu President | Sep 11, 2026 | Option exercise | +15,000 | $2.59 | $38.85K | 80,179 |
| Peng Lu President | Sep 11, 2026 | Sale(10b5-1 plan) | −15,000 | $40.13 | $601.95K | 65,179 |
| Peng Lu President | Sep 11, 2026 | Tax withholding | −109 | $37.51 | $4.09K | 65,070 |
| Anne Lesage Chief Early Development | Sep 10, 2026 | Sale(10b5-1 plan) | −30,000 | $38.30 | $1.15M | 56,450 |
| Anne Lesage Chief Early Development | Sep 10, 2026 | Option exercise | +30,000 | $8.05 | $241.50K | 86,450 |
| Robert Glassman Director | Sep 9, 2026 | Option exercise | +8,000 | $20.00 | $160.00K | 18,500 |
| Robert Glassman Director | Sep 9, 2026 | Sale(10b5-1 plan) | −8,000 | $37.55 | $300.40K | 10,500 |
| Peng Lu President | Sep 8, 2026 | Sale(10b5-1 plan) | −15,000 | $40.68 | $610.20K | 65,179 |
| Peng Lu President | Sep 8, 2026 | Option exercise | +15,000 | $2.59 | $38.85K | 80,179 |
| Berndt Modig Chief Executive Officer, Director | Aug 14, 2026 | Sale(10b5-1 plan) | −2,292 | $34.77 | $79.69K | 130,625 |
| Peng Lu President | Aug 12, 2026 | Tax withholding | −117 | $34.42 | $4.03K | 65,179 |
| Peng Lu President | Aug 11, 2026 | Tax withholding | −109 | $34.84 | $3.80K | 65,296 |
| Berndt Modig Chief Executive Officer, Director | Jul 13, 2026 | Sale(10b5-1 plan) | −2,292 | $34.97 | $80.15K | 132,917 |
| Peng Lu Chief Medical Officer | Jul 12, 2026 | Tax withholding | −117 | $35.07 | $4.10K | 65,405 |
| Peng Lu Chief Medical Officer | Jul 11, 2026 | Tax withholding | −109 | $35.07 | $3.82K | 65,522 |
| Johannes Gerardus Christiaan Petrus Schikan Director | Jun 30, 2026 | Sale(10b5-1 plan) | −30,712 | $35.49 | $1.09M | 315,167 |
| Anne Lesage Chief Early Development | Jun 30, 2026 | Sale(10b5-1 plan) | −30,703 | $35.49 | $1.09M | 93,969 |
| Anne Lesage Chief Early Development | Jun 30, 2026 | Sale(10b5-1 plan) | −27,872 | $35.48 | $988.90K | 58,750 |
| Anne Lesage Chief Early Development | Jun 30, 2026 | Option exercise | +24,900 | $8.05 | $200.45K | 86,622 |
| Anne Lesage Chief Early Development | Jun 30, 2026 | Option exercise | +2,972 | $2.59 | $7.70K | 61,722 |
| Johannes Gerardus Christiaan Petrus Schikan Director | Jun 29, 2026 | Sale(10b5-1 plan) | −6,888 | $35.05 | $241.42K | 345,879 |
| Anne Lesage Chief Early Development | Jun 29, 2026 | Sale(10b5-1 plan) | −6,997 | $35.05 | $245.24K | 124,672 |
| Anne Lesage Chief Early Development | Jun 29, 2026 | Sale(10b5-1 plan) | −8,300 | $35.05 | $290.92K | 58,750 |
| Anne Lesage Chief Early Development | Jun 29, 2026 | Sale(10b5-1 plan) | −2,300 | $35.12 | $80.78K | 56,450 |
| Anne Lesage Chief Early Development | Jun 29, 2026 | Option exercise | +4,200 | $8.05 | $33.81K | 67,050 |
| Anne Lesage Chief Early Development | Jun 29, 2026 | Option exercise | +4,100 | $2.59 | $10.62K | 56,450 |
| Anne Lesage Chief Early Development | Jun 29, 2026 | Option exercise | +900 | $8.05 | $7.25K | 58,750 |
| Anne Lesage Chief Early Development | Jun 29, 2026 | Option exercise | +1,400 | $2.59 | $3.63K | 57,850 |
| Johannes Gerardus Christiaan Petrus Schikan Director | Jun 29, 2026 | Sale(10b5-1 plan) | −2,400 | $35.10 | $84.24K | 352,767 |
| Peng Lu Chief Medical Officer | Jun 26, 2026 | Option exercise | +14,700 | $2.59 | $38.07K | 80,331 |
| Peng Lu Chief Medical Officer | Jun 26, 2026 | Sale(10b5-1 plan) | −14,700 | $34.00 | $499.80K | 65,631 |
| Peng Lu Chief Medical Officer | Jun 25, 2026 | Option exercise | +15,000 | $2.59 | $38.85K | 80,631 |
| Peng Lu Chief Medical Officer | Jun 25, 2026 | Sale(10b5-1 plan) | −11,600 | $34.45 | $399.62K | 69,031 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Rosine Francoise Beck Monges Viviane Director | Sep 23, 2026 | 11,969 | $395.52K | Sep 23, 2026 | Exercise of Options Under a Registered Plan |
| Ger. Chris. Pe Schikan Johannes Officer, Director | Sep 22, 2026 | 200,000 | $7.00M | Sep 17, 2026 | Founder Stock |
| Ger. Chris. Pe Schikan Johannes Director | Sep 22, 2026 | 800 | $28.95K | Sep 22, 2026 | Exercise of Options Under a Registered Plan |
| Nassif David Officer | Sep 21, 2026 | 6,000 | $218.80K | Sep 21, 2026 | Restricted Stock |
| Lu Peng Officer | Sep 17, 2026 | 100,000 | $3.50M | Sep 17, 2026 | Exercise of Options Under a Registered Plan |
| Ger. Chris. Pe Schikan Johannes Officer, Director | Sep 17, 2026 | 200,000 | $7.00M | Sep 17, 2026 | Founder Stock |
| Management Bv Schoodic Officer, Director | Sep 17, 2026 | 300,000 | $10.50M | Sep 17, 2026 | Founder Stock |
| E. Bjork Elisabeth Director | Sep 17, 2026 | 52,500 | $1.99M | Sep 17, 2026 | Stock Option Exercise |
| Consulting Graymatters Officer | Sep 17, 2026 | 20,000 | $765.47K | Sep 17, 2026 | Founder Stock |
| Glassman Robert Director | Sep 17, 2026 | 14,493 | $558.81K | Sep 17, 2026 | Stock Option Exercise |
| Abele Stefan Officer | Sep 15, 2026 | 46,400 | $1.77M | Sep 15, 2026 | Stock Option Exercise |
| Glassman Robert Director | Sep 15, 2026 | 8,667 | $331.72K | Sep 15, 2026 | Stock Option Exercise |
| Berndt B.A,E. Modig Director, Officer | Sep 14, 2026 | 2,291 | $87.10K | Sep 14, 2026 | Restricted Stock Units |
| Souverijns Wim Officer | Sep 14, 2026 | 26,090 | $1.02M | Sep 14, 2026 | Restricted Stock |
| Lesage Anne Officer | Sep 10, 2026 | 30,000 | $1.15M | Sep 10, 2026 | Stock Option Exercise |